These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8359563)

  • 21. Sandostatin desensitization--a strategy useful for patients with carcinoid tumors, intolerant to sandostatin.
    Vinjamaram S; Iyer R
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):225-6. PubMed ID: 20922390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sandostatin and the Belfast experience.
    Buchanan KD; Collins JS; Varghese A; Johnston CF; Shaw C
    Digestion; 1990; 45 Suppl 1():11-4; discussion 15-6. PubMed ID: 2159429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques.
    Grimes J; Celler A
    Med Phys; 2014 Sep; 41(9):092501. PubMed ID: 25186410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges, strategies and tools to optimize the management of ocular allergy. Proceedings of the 1st International Symposium. Monte Carlo, Monaco, June 22-25, 1998.
    Acta Ophthalmol Scand Suppl; 1999; (228):1-56. PubMed ID: 10970144
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of a new antipsychotic Remoxipride. Proceedings of an international symposium. Monte Carlo, Monaco, June 19-20, 1989.
    Acta Psychiatr Scand Suppl; 1990; 358():1-188. PubMed ID: 1978466
    [No Abstract]   [Full Text] [Related]  

  • 26. [Octreotide Symposium. 4-5 May 1990, Frankfurt. Proceedings].
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():1-60. PubMed ID: 1980769
    [No Abstract]   [Full Text] [Related]  

  • 27. [Application of sandostatin in malignant bowel obstruction].
    Li J; Jing ML; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):479-81. PubMed ID: 17851794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical progress with LHRH analogues in prostatic cancer. Proceedings of an international symposium. Monte Carlo, 20 January 1990.
    J Int Med Res; 1990; 18 Suppl 1():1-125. PubMed ID: 2108881
    [No Abstract]   [Full Text] [Related]  

  • 29. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.
    Yuen MF; Poon RT; Lai CL; Fan ST; Lo CM; Wong KW; Wong WM; Wong BC
    Hepatology; 2002 Sep; 36(3):687-91. PubMed ID: 12198662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 30th International Symposium on GH and Growth Factors in Endocrinology and Metabolism. Monte Carlo, Monaco, October 6-7, 2000. Proceedings and abstracts.
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():1-160. PubMed ID: 11808495
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sandostatin in the treatment of diarrhea of different origins].
    Belousova EA; Zlatkina AR; Mishurovskaia TS; Bezzubik KV
    Ter Arkh; 1995; 67(7):62-5. PubMed ID: 7482310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective randomized controlled trial of sandostatin and vasopressin in the management of acute bleeding esophageal varices.
    Huang CC; Sheen IS; Chu CM; Chuah SK; Chien RN; Peng SM; Kuo YC; Lin SM; Lin DY; Chen PC
    Changgeng Yi Xue Za Zhi; 1992 Jun; 15(2):78-83. PubMed ID: 1515974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of gastrointestinal neuroendocrine tumors with the somatostatin analog octreotide (Sandostatin)].
    Stöckmann F; Creutzfeldt W
    Z Gastroenterol; 1988 Oct; 26(10):665-75. PubMed ID: 2849248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Somatostatin and Octreotide in Pancreatic Disease. Proceedings of a Symposium at the EPC meeting. Ulm, Germany, October 12, 1992.
    Digestion; 1994; 55 Suppl 1():1-51. PubMed ID: 7907563
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of sandostatin on sphincter of Oddi in acute severe pancreatitis in dogs].
    Zhu Q; Yuan Y; Xia L; Xu J
    Zhonghua Nei Ke Za Zhi; 1999 Nov; 38(11):747-9. PubMed ID: 11798715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sandostatin causing reversible thrombocytopenia.
    Chisholm S; Gummadi B; Vega KJ; House J
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):474-5. PubMed ID: 19242360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From somatostatin to Sandostatin: pharmacodynamics and pharmacokinetics.
    Marbach P; Briner U; Lemaire M; Schweitzer A; Terasaki T
    Digestion; 1993; 54 Suppl 1():9-13. PubMed ID: 8103016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future medical prospects for Sandostatin.
    Harris AG
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():55-60. PubMed ID: 1980778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.
    Lemaire M; Azria M; Dannecker R; Marbach P; Schweitzer A; Maurer G
    Drug Metab Dispos; 1989; 17(6):699-703. PubMed ID: 2575511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial inhibition of the growth of transplanted dunning rat prostate tumors with the long-acting somatostatin analogue sandostatin (SMS 201-995).
    Siegel RA; Tolcsvai L; Rudin M
    Cancer Res; 1988 Aug; 48(16):4651-5. PubMed ID: 2899458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.